Dow Up0.35% Nasdaq Down0.02%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
5.08 0.50(10.92%) Aug 20, 4:00PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Assets
Current Assets
Cash And Cash Equivalents34,423  36,594  10,489  9,715  
Short Term Investments -   -   -   -  
Net Receivables -   -   -   -  
Inventory -   -   -   -  
Other Current Assets87  151  198  27  
Total Current Assets 34,510   36,745   10,687   9,742  
Long Term Investments63  130   -   -  
Property Plant and Equipment2  3  3  5  
Goodwill -   -   -   -  
Intangible Assets19  21  23  24  
Accumulated Amortization -   -   -   -  
Other Assets -   -   -  6  
Deferred Long Term Asset Charges -   -   -   -  
Total Assets 34,594   36,899   10,713   9,777  
Liabilities
Current Liabilities
Accounts Payable2,147  1,937  2,486  1,603  
Short/Current Long Term Debt -   -   -   -  
Other Current Liabilities -   -   -   -  
Total Current Liabilities 2,147   1,937   2,486   1,603  
Long Term Debt -   -   -   -  
Other Liabilities -   -   -  1  
Deferred Long Term Liability Charges -   -   -   -  
Minority Interest -   -   -   -  
Negative Goodwill -   -   -   -  
Total Liabilities 2,147   1,937   2,486   1,604  
Stockholders' Equity
Misc Stocks Options Warrants1,781  1,811   -  2,105  
Redeemable Preferred Stock4,942  4,885  6,746  4,768  
Preferred Stock567  587  587  632  
Common Stock22  22  18  18  
Retained Earnings(111,104)(107,373)(101,965)(98,850)
Treasury Stock -   -   -   -  
Capital Surplus136,239  135,030  102,841  99,500  
Other Stockholder Equity -   -   -   -  
Total Stockholder Equity 25,724   28,266   1,481   1,300  
Net Tangible Assets 25,705   28,245   1,458   1,276  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.